
Sterling announces strategic investment in ADC Biotechnology
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling), has announced a new strategic partnership with ADC Biotechnology (ADC Bio), a UK based biotechnology company specialising in antibody drug conjugates. The partnership will see Sterling make a significant investment in the business with a view to acquiring ADC… Read More







